Align Technology, Inc. (ALGN) has been making waves in the dental industry with its innovative clear aligners, most notably known for its Invisalign product. With over 90% market share, ALGN has established itself as a leader in the industry, commanding a strong brand moat and investor enthusiasm. Despite historically trading at high valuations, the stock has recently experienced a correction, presenting a potential buying opportunity for investors.
Currently trading at $188.07 as of 10th June, ALGN’s trailing and forward P/E ratios stand at 32.9 and 17.7 respectively. This suggests that the stock may be undervalued, with a fair value estimate of $200 based on an average EPS of 10.8. This indicates a potential discount of around 20% from current levels, offering investors a chance for ~10% annual returns if the multiple remains steady.
Align Technology’s moat is built on intangible assets such as SmartTrack materials and decades of clinical data, as well as high switching costs for doctors and indirect network effects. While the company lacks a cost advantage or natural scale barriers, its capital allocation strategy is conservative, with a focus on R&D and strategic acquisitions like Exocad to drive innovation.
Morningstar supports the undervaluation thesis, assigning a fair value of $240 and a narrow moat rating to ALGN. Despite macro and competitive risks, the company’s track record of meeting or exceeding analyst expectations lends confidence to forward projections. This, coupled with its growth-oriented posture and strong brand presence, positions Align as a high-quality business trading at a fair price.
In conclusion, Align Technology, Inc. presents an attractive investment opportunity for investors comfortable with industry cyclicality and valuation-driven risk. With a solid track record, innovative products, and a focus on long-term growth, ALGN is poised for growth and potential upside for shareholders.
